Your browser doesn't support javascript.
loading
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.
Eyre, Toby A; Lamanna, Nicole; Roeker, Lindsey E; Ujjani, Chaitra S; Hill, Brian T; Barr, Paul M; Lansigan, Erick; Cheson, Bruce D; Yazdy, Maryam; Allan, John N; Rhodes, Joanna; Schuster, Stephen J; Nabhan, Chadi; Skarbnik, Alan; Leslie, Lori; Islam, Prioty; Whitaker, Katherine; Coombs, Catherine C; Tuncer, Hande H; Pagel, John M; Jacobs, Ryan; Winter, Allison M; Bailey, Neil; Sitlinger, Andrea; Schuh, Anna H; Follows, George; Fox, Christopher P; Brander, Danielle M; Shadman, Mazyar; Mato, Anthony R.
Afiliação
  • Eyre TA; Hematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
  • Lamanna N; New York-Presbyterian Columbia University Medical Center, New York, NY.
  • Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ujjani CS; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Hill BT; Dept. of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation.
  • Barr PM; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Lansigan E; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
  • Cheson BD; Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.
  • Yazdy M; Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.
  • Allan JN; Weill Cornell Medicine School of Medicine, Long Island City, NY.
  • Rhodes J; Div. of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Schuster SJ; Div of Hematology and Oncology,Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Nabhan C; Aptitude Health, Atlanta, GA.
  • Skarbnik A; Novant Health, Charlotte, NC.
  • Leslie L; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.
  • Islam P; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
  • Whitaker K; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
  • Tuncer HH; Department of Medicine, Cancer Center, Tufts Medical Center, Boston, MA.
  • Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA.
  • Jacobs R; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC.
  • Winter AM; Dept of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation.
  • Bailey N; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA.
  • Sitlinger A; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
  • Schuh AH; Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
  • Follows G; Department of Haematology, Addenbrookes, Cambridge.
  • Fox CP; Nottingham University Hospitals NHS Trust, Nottingham.
  • Brander DM; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
  • Shadman M; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Mato AR; Memorial Sloan Kettering Cancer Center, New York, NY.
Haematologica ; 106(1): 284-287, 2021 01 01.
Article em En | MEDLINE | ID: mdl-32079693

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article